论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
miR-1271 通过靶向卵巢癌细胞中的 ZEB1 抑制生长、侵袭和上皮-间质转化
Authors Jiao Y, Zhu G, Yu J, Li Y, Wu M, Zhao J, Tian X
Received 11 June 2019
Accepted for publication 8 August 2019
Published 28 August 2019 Volume 2019:12 Pages 6973—6980
DOI https://doi.org/10.2147/OTT.S219018
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Ms Shreya Arora
Peer reviewer comments 4
Editor who approved publication: Dr Takuya Aoki
Objective: MicroRNA-1271 (miR-1271) has a role in suppressing cell growth, cell cycle and promoting cell apoptosis in many cancers. This research was to explore the great role of miR-1271 in ovarian cancer (OC).
Patients and Methods: RT-qPCR was utilized to evaluate the mRNA levels of miR-1271 and its target gene. The proliferative and invasive abilities were measured using Cell Counting Kit-8 and transwell assays. The overall survival rate of OC patients was assessed by Kaplan–Meier method.
Results: miR-1271 was downregulated in OC tissues, and downregulation of miR-1271 predicted a poor outcome of the OC patients. Zinc finger E-box binding homeobox 1 (ZEB1) was a target gene of miR-1271 and its expression was regulated by miR-1271 in OC. The expression of miR-1271 had a negative connection with the expression of ZEB1 in OC tissues. miR-1271 inhibited cell viability and invasion-mediated epithelial–mesenchymal transition in SKOV3 cells. ZEB1 reversed partial roles of miR-1271 on viability and invasion in OC.
Conclusion: miR-1271 inhibited cell proliferation and invasion-mediated EMT in OC. The newly identified miR-1271/ZEB1 axis provides novel insight into the pathogenesis of OC.
Keywords: miR-1271, proliferation, invasion, epithelial–mesenchymal transition (EMT), ovarian cancer
